Universidad CEU San Pablo-ko ikertzaileekin lankidetzan egindako argitalpenak (10)

2023

  1. Hemihypomimia in Parkinson’s disease: an under-recognized clinical sign?

    Journal of Neurology

2022

  1. Home-based transcranial static magnetic field stimulation of the motor cortex for treating levodopa-induced dyskinesias in Parkinson's disease: A randomized controlled trial

    Brain Stimulation

2020

  1. Abnormal pattern of brain glucose metabolism in Parkinson’s disease: replication in three European cohorts

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 47, Núm. 2, pp. 437-450

2019

  1. Neuroimaging biomarkers for clinical trials in atypical parkinsonian disorders: Proposal for a Neuroimaging Biomarker Utility System

    Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring, Vol. 11, pp. 301-309

  2. Parkinson’s disease with mild cognitive impairment: severe cortical thinning antedates dementia

    Brain Imaging and Behavior, Vol. 13, Núm. 1, pp. 180-188

2018

  1. Pooled-DNA target sequencing of Parkinson genes reveals novel phenotypic associations in Spanish population

    Neurobiology of Aging, Vol. 70, pp. 325.e1-325.e5

  2. Subthalamotomy for Parkinson's disease: Clinical outcome and topography of lesions

    Journal of Neurology, Neurosurgery and Psychiatry, Vol. 89, Núm. 6, pp. 572-578

  3. Transcranial static magnetic field stimulation (tSMS) of the visual cortex decreases experimental photophobia

    Cephalalgia, Vol. 38, Núm. 8, pp. 1493-1497

2016

  1. Significance of visual hallucinations and cerebral hypometabolism in the risk of dementia in Parkinson's disease patients with mild cognitive impairment

    Human Brain Mapping, Vol. 37, Núm. 3, pp. 968-977

2015

  1. Parkinson's disease, the subthalamic nucleus, inhibition, and impulsivity

    Movement Disorders, Vol. 30, Núm. 2, pp. 128-140